Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6247 |
Onvansertib
NMS-P937,NMS-1286937 |
Apoptosis; PLK | Apoptosis; Cell Cycle/Checkpoint |
Onvansertib (NMS-1286937) 是一种可口服的高选择性PLK1抑制剂,IC50值为 2 nM。 | |||
T71085 |
BMS-824
|
||
BMS-824 is a potent NS5A inhibitor. The 50% inhibition of HCV replicon replication for BMS-824 was approximately 5 nM, with a therapeutic index of >10,000. BMS-824 showed good specificity for HCV, as it was not active against several other RNA and DNA viruses. |